Blood product usage
Over the past two decades, researchers have emphasised both the positive and negative effects of blood product usage and highlighted the importance of the identification and management of anaemia. We now have a clearer, although not complete, understanding of rational and appropriate blood product usage, with several guidelines and changes in the strategies for blood product administration. This shift in thinking has included the introduction of ‘Patient Blood Management’ (PBM) – the application of evidence-based practices to optimise patient outcomes by managing and preserving the patient’s own blood. Recently proposed as a potential solution for the South African context, PBM is particularly relevant considering the high prevalence of anaemia in our population, the severe blood product shortages, dwindling blood donor pool, and high demand for blood products.1
By submitting manuscripts to SAJAA, authors of original articles are assigning copyright to the SA Society of Anaesthesiologists. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJAA for educational and research purposes without obtaining permission.
The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License. The SAJAA does not hold itself responsible for statements made by the authors.